Zhang BH - Search Results

1

Hepatocellular Carcinoma: The Role of Screening.

Zhou XD, Tang ZY, Yang BH, Zhang BH. Zhou XD, et al. Among authors: zhang bh. Asian Pac J Cancer Prev. 2000;1(2):121-126. Asian Pac J Cancer Prev. 2000. PMID: 12718678 Free article.

2

Randomized controlled trial of screening for hepatocellular carcinoma.

Zhang BH, Yang BH, Tang ZY. Zhang BH, et al. J Cancer Res Clin Oncol. 2004 Jul;130(7):417-22. doi: 10.1007/s00432-004-0552-0. J Cancer Res Clin Oncol. 2004. PMID: 15042359 Clinical Trial.

3

[Effect of postoperative transcatheter arterial chemoembolization on hepatocellular carcinoma patients with residual tumor].

Ren ZG, Lin ZY, Xia JL, Zhang BH, Ye SL, Chen SY, Gan YH, Wu XF, Chen Y, Ge NL, Wu ZQ, Ma ZC, Zhou XD, Fan J, Qin LX, Ye QH, Sun HC, Zhou J, Tang ZY. Ren ZG, et al. Among authors: zhang bh. Zhonghua Zhong Liu Za Zhi. 2004 Feb;26(2):116-8. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15059334 Chinese.

4

The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma.

Zhang H, Ye QH, Ren N, Zhao L, Wang YF, Wu X, Sun HC, Wang L, Zhang BH, Liu YK, Tang ZY, Qin LX. Zhang H, et al. Among authors: zhang bh. J Cancer Res Clin Oncol. 2006 Nov;132(11):709-17. doi: 10.1007/s00432-006-0119-3. Epub 2006 Jun 20. J Cancer Res Clin Oncol. 2006. PMID: 16786357

5

Circulating DNA level is negatively associated with the long-term survival of hepatocellular carcinoma patients.

Ren N, Ye QH, Qin LX, Zhang BH, Liu YK, Tang ZY. Ren N, et al. Among authors: zhang bh. World J Gastroenterol. 2006 Jun 28;12(24):3911-4. doi: 10.3748/wjg.v12.i24.3911. World J Gastroenterol. 2006. PMID: 16804981 Free PMC article.

6

P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinoma.

Qian YB, Zhang JB, Wu WZ, Fang HB, Jia WD, Zhuang PY, Zhang BH, Pan Q, Xu Y, Wang L, Tang ZY, Sun HC. Qian YB, et al. Among authors: zhang bh, zhang jb. Cancer. 2006 Oct 1;107(7):1562-9. doi: 10.1002/cncr.22206. Cancer. 2006. PMID: 16948122 Free article.

7

Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection.

Cai MY, Xu YF, Qiu SJ, Ju MJ, Gao Q, Li YW, Zhang BH, Zhou J, Fan J. Cai MY, et al. Among authors: zhang bh. Clin Cancer Res. 2009 Jul 15;15(14):4686-93. doi: 10.1158/1078-0432.CCR-09-0463. Epub 2009 Jul 7. Clin Cancer Res. 2009. PMID: 19584149

8

CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.

Yang XR, Xu Y, Yu B, Zhou J, Li JC, Qiu SJ, Shi YH, Wang XY, Dai Z, Shi GM, Wu B, Wu LM, Yang GH, Zhang BH, Qin WX, Fan J. Yang XR, et al. Among authors: zhang bh. Clin Cancer Res. 2009 Sep 1;15(17):5518-27. doi: 10.1158/1078-0432.CCR-09-0151. Epub 2009 Aug 25. Clin Cancer Res. 2009. PMID: 19706825

9

Risk factors for residual tumor after resection of hepatocellular carcinoma.

Chen XH, Zhang BH, Xin Y, Ren ZG, Fan J, Qiu SJ, Zhou J. Chen XH, et al. Among authors: zhang bh. World J Gastroenterol. 2011 Apr 14;17(14):1889-94. doi: 10.3748/wjg.v17.i14.1889. World J Gastroenterol. 2011. PMID: 21528064 Free PMC article.

10

Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.

Yin X, Zhang BH, Qiu SJ, Ren ZG, Zhou J, Chen XH, Zhou Y, Fan J. Yin X, et al. Among authors: zhang bh. Ann Surg Oncol. 2012 Sep;19(9):2869-76. doi: 10.1245/s10434-012-2328-0. Epub 2012 Mar 27. Ann Surg Oncol. 2012. PMID: 22451237

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

550 results

Search Page

Filters